National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2015 (PB 32 of 2015)

Overview

The National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2015 was enacted to amend the National Health (IVF/GIFT Program) Special Arrangement 2011. This legislative instrument was introduced under the authority of the National Health Act 1953, specifically sections 100(1) and 100(2), which enable the Minister to make special arrangements for the supply of pharmaceutical benefits and to vary or revoke such arrangements, respectively. The amendment responds to changes in the National Health (Pharmaceutical Benefits) Regulations 1960, which introduced transitional provisions for hospital medication chart prescriptions, thus necessitating an update to the IVF/GIFT Special Arrangement. The objective of this legislative instrument is to ensure that the IVF/GIFT Special Arrangement does not apply to these new medication chart prescriptions, reflecting a careful approach to integrating new health care practices while balancing patient access and health outcomes. Consultations involving various health stakeholders, including states and territories, professional health associations, and patient advocacy groups, have supported the trial and implementation of the new medication chart prescriptions. This legislative amendment aligns with broader regulatory changes and supports the progressive realisation of health rights under international human rights instruments by facilitating access to essential medicines through the Pharmaceutical Benefits Scheme. The instrument commenced on 1 April 2015, ensuring a smooth transition and providing adequate time to assess the impact of the new prescription practices on the IVF/GIFT Program.

Scope and Application

The National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2015 applies to the National Health (IVF/GIFT Program) Special Arrangement 2011 under the National Health Act 1953, providing an amendment to the arrangement in response to changes in the National Health (Pharmaceutical Benefits) Regulations 1960. Specifically, the amendment ensures that the IVF/GIFT Special Arrangement does not apply to medication chart prescriptions. This change was made to accommodate the transitional period for hospital medication chart prescriptions within the Pharmaceutical Benefits Scheme (PBS) and Repatriation PBS (RPBS), allowing for trial access and additional time to assess the use of these prescriptions under the Special Arrangement. The instrument applies nationally as it is an amendment to the National Health Act, which has a Commonwealth jurisdictional reach. There are no specific exclusions or thresholds mentioned in the text, but the instrument's scope is limited to the amendment of the IVF/GIFT Special Arrangement in relation to medication chart prescriptions. Subordinate instruments, such as the National Health (Pharmaceutical Benefits) Amendment (Medication Chart Prescriptions) Regulation 2015, extend and detail the application of the Act by providing the regulatory framework for medication chart prescriptions.

Key Provisions

The main operative sections of the National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2015 (subsections 100(1) and 100(2) of the National Health Act 1953) aim to amend the National Health (IVF/GIFT Program) Special Arrangement 2011. Specifically, the amendment excludes medication chart prescriptions from the scope of the Special Arrangement, aligning with the changes introduced by the National Health (Pharmaceutical Benefits) Amendment (Medication Chart Prescriptions) Regulation 2015. This adjustment reflects the transitional period provided for hospital medication chart prescriptions under the Pharmaceutical Benefits Scheme (PBS) and Repatriation PBS (RPBS), facilitating trial access and allowing stakeholders time to evaluate the integration of these prescriptions within the IVF/GIFT Program. The amendment imposes certain obligations on the parties involved. For instance, healthcare providers and pharmacists must ensure that medication chart prescriptions are not processed under the IVF/GIFT Special Arrangement, instead adhering to the regulations governing PBS and RPBS prescriptions. This includes following the transitional guidelines set forth in the National Health (Pharmaceutical Benefits) Regulations 1960, as amended. The Department of Health and other relevant entities are also required to monitor the implementation of these changes to ensure compliance and to evaluate the impact of the new arrangements on the IVF/GIFT Program. Breaches of the amended Special Arrangement may result in various civil and criminal consequences. For example, healthcare providers who continue to process medication chart prescriptions under the IVF/GIFT Special Arrangement could face penalties for non-compliance with the amended regulations. The specific penalties for such breaches are not detailed in the instrument but are generally governed by the National Health Act 1953 and the National Health (Pharmaceutical Benefits) Regulations 1960. These penalties could include fines or other administrative sanctions, depending on the severity and frequency of the non-compliance. Additionally, individuals or entities found to be deliberately circumventing the regulations could face more severe criminal charges, potentially leading to imprisonment or substantial fines.